Research article · 12 Jun 2025
Conference abstractPublished 2015
SNEDDS is the key in a peptide protection towards luminal enzymes
University Innsbruck, Austria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: The aim of this study is the development of self-nanoemulsifying drug delivery systems (SNEDDS) with improved resistance towards pancreatic lipases andwith protective effect against luminal enzymatic metabolism using leuprorelin as model peptide drug. Material & Methods: Hydrophobic leuprolide oleate obtained after leuprolide acetate complexation with sodium oleate was incorporated into three different SNEDDS formulations. SNEDDS stability towards pancreatic lipases was investigated utilizing a dynamic in vitro digestion model simulating small intestinal digestion. Protective effect of SNEDDS in respect to peptide drug stability against proteolytic enzymes, trypsin and alfa- chymotrypsin, was determined via HPLC. Leuprorelin acetate in an aqueous control solution served as control. Results: All formulations were dispersed in a concentration of 1% (m/v) in simulated gastrointestinal fluid at pH 6.5. Results of in vitro digestion demonstrated that 80% of SNEDDS containing the highest amount of ester linkages was degraded within 60 min. In comparison to that, SNEDDS without ester bonds showed no degradation. With increasing oil droplets hydrolysis the remaining amount of peptide encapsulated into formulation decreased. Furthermore, after 180 min incubation with trypsin up to 33.5% and with chymotrypsin up to 60.5% of leuprolide oleate was still intact while control solution was completely metabolized by trypsin within 120 min and by α-chymotrypsin within 5 min. Protective effect in environment containing lipases was lower due to oil phase degradation, however, the amount of peptide in SNEDDS free of ester linkages was remarkably higher (48.14%) compared to control solution and SNEDDS susceptible to lipases. Conclusion: The present study revealed that SNEDDS which are stable towards hydrolysis are able to exhibit a protective effect for oral peptide delivery.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Gintare Leonaviciute”
- BylineArticles whose byline prints “O Zupancic”
- BylineArticles whose byline prints “F Prüfert”
- BylineArticles whose byline prints “J Rohrer”
- BylineArticles whose byline prints “A Bernkop-Schnürch”
